Adiponectin and cardiovascular health: An update

British Journal of Pharmacology

Volumn 165, Issue 3, 2012, Pages 574-590

  Hui, Xiaoyan ^a   Lam, Karen Sl ^a   Vanhoutte, Paul M ^a   Xu, Aimin ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

adipokine; adiponectin; cardiovascular disease; endothelial dysfunction; inflammation; obesity; vasculature

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; ANGIOTENSIN RECEPTOR ANTAGONIST; BEZAFIBRATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FENOFIBRATE; FISH OIL; GRAPE SEED EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 10; INTERLEUKIN 6; LOSARTAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NUTRACEUTICAL; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PIOGLITAZONE; REACTIVE OXYGEN METABOLITE; RESVERATROL; ROSIGLITAZONE; SAFFLOWER OIL; SIMVASTATIN; SPHINGOSINE 1 PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANTIOXIDANT ACTIVITY; ARTERIAL WALL THICKNESS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CYTOKINE RELEASE; DIABETIC CARDIOMYOPATHY; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRACELLULAR SIGNALING; LIFESTYLE MODIFICATION; NITROSATIVE STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; WEIGHT REDUCTION;

ADIPONECTIN; ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; RECEPTORS, ADIPONECTIN; THIAZOLIDINEDIONES;

EID: 81855177709     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01395.x     Document Type: Review

References (188)

1. Amin RH, Mathews ST, Alli A, Leff T, (2010a). Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARgamma-dependent autocrine mechanism. Am J Physiol Heart Circ Physiol 299: H690-H698.
2. Amin RH, Mathews ST, Camp HS, Ding L, Leff T, (2010b). Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance. Am J Physiol Endocrinol Metab 298: E28-E37.
3. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al,. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83. (Pubitemid 29299050)
4. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, et al,. (2002). Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105: 2893-2898. (Pubitemid 34666104)
5. Bacha F, Saad R, Gungor N, Arslanian SA, (2004). Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 27: 547-552. (Pubitemid 38174085)
6. Bjursell M, Ahnmark A, Bohlooly YM, William-Olsson L, Rhedin M, Peng XR, et al,. (2007). Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 56: 583-593. (Pubitemid 46348449)
7. Cambuli VM, Musiu MC, Incani M, Paderi M, Serpe R, Marras V, et al,. (2008). Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children. J Clin Endocrinol Metab 93: 3051-3057.
8. Cao Y, Tao L, Yuan Y, Jiao X, Lau WB, Wang Y, et al,. (2009). Endothelial dysfunction in adiponectin deficiency and its mechanisms involved. J Mol Cell Cardiol 46: 413-419.
9. Chang J, Li Y, Huang Y, Lam KS, Hoo RL, Wong WT, et al,. (2010). Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway. Diabetes 59: 2949-2959.
10. Charlton HK, Webster J, Kruger S, Simpson F, Richards AA, Whitehead JP, (2010). ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signalling. Biochem Biophys Res Commun 392: 234-239.
11. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ, (2003). Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278: 45021-45026. (Pubitemid 37377262)
12. Chen Z, Peng IC, Sun W, Su MI, Hsu PH, Fu Y, et al,. (2009a). AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633. Cir Res 104: 496-505.
13. Chen X, Sebastian BM, Tang H, McMullen MM, Axhemi A, Jacobsen DW, et al,. (2009b). Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats. Hepatology 49: 1554-1562.
14. Cheng KK, Lam KS, Wang Y, Huang Y, Carling D, Wu D, et al,. (2007). Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 56: 1387-1394. (Pubitemid 46715600)
15. Cheng KK, Iglesias MA, Lam KS, Wang Y, Sweeney G, Zhu W, et al,. (2009). APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab 9: 417-427.
16. Chinetti G, Zawadski C, Fruchart JC, Staels B, (2004). Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem Biophys Res Commun 314: 151-158. (Pubitemid 38058382)
17. Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, Fong CH, et al,. (2007). Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 49: 1455-1461. (Pubitemid 46809394)
18. Clasen R, Schupp M, Foryst-Ludwig A, Sprang C, Clemenz M, Krikov M, et al,. (2005). PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin. Hypertension 46: 137-143. (Pubitemid 40946504)
19. Deng G, Long Y, Yu YR, Li MR, (2010). Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway. Int J Obes (Lond) 34: 165-171.
20. Denzel MS, Scimia MC, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B, (2010). T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest 120: 4342-4352.
21. Devaraj S, Torok N, Dasu MR, Samols D, Jialal I, (2008). Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-tissue-vascular loop. Arterioscler Thromb Vasc Biol 28: 1368-1374.
22. Ding G, Qin Q, He N, Francis-David SC, Hou J, Liu J, et al,. (2007). Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma. J Mol Cell Cardiol 43: 73-84. (Pubitemid 46898422)
23. Dong F, Ren J, (2009). Adiponectin improves cardiomyocyte contractile function in db/db diabetic obese mice. Obesity (Silver Spring) 17: 262-268.
24. Ebinc H, Ebinc FA, Ozkurt ZN, Dogru MT, Tulmac M, Yilmaz M, et al,. (2008). Impact of adiponectin on left ventricular mass index in non-complicated obese subjects. Endocr J 55: 523-528. (Pubitemid 351949747)
25. Eren P, Camus S, Matrone G, Ebrahimian TG, Francois D, Tedgui A, et al,. (2009). Adiponectinemia controls pro-angiogenic cell therapy. Stem Cells 27: 2712-2721.
26. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al,. (2003). Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289: 1799-1804. (Pubitemid 37430249)
27. Fadini GP, Sartore S, Agostini C, Avogaro A, (2007). Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care 30: 1305-1313. (Pubitemid 46684670)
28. Fang X, Palanivel R, Cresser J, Schram K, Ganguly R, Thong FS, et al,. (2010). An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart. Am J Physiol Endocrinol Metab 299: E721-E729.
29. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, Hensler M, et al,. (2006). Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49: 394-397. (Pubitemid 43185410)
30. Frizzell N, Rajesh M, Jepson MJ, Nagai R, Carson JA, Thorpe SR, et al,. (2009). Succination of thiol groups in adipose tissue proteins in diabetes: succination inhibits polymerization and secretion of adiponectin. J Biol Chem 284: 25772-25781.
31. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B, (2007). Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 92: 571-576.
32. Fujioka D, Kawabata K, Saito Y, Kobayashi T, Nakamura T, Kodama Y, et al,. (2006). Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am J Physiol Heart Circ Physiol 290: H2409-H2416. (Pubitemid 43846069)
33. Fujita K, Maeda N, Sonoda M, Ohashi K, Hibuse T, Nishizawa H, et al,. (2008). Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha. Arterioscler Thromb Vasc Biol 28: 863-870. (Pubitemid 351544100)
34. Furuhashi M, Ura N, Higashiura K, Murakami H, Tanaka M, Moniwa N, et al,. (2003). Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 42: 76-81. (Pubitemid 36842239)
35. Furukawa K, Hori M, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, et al,. (2004). Adiponectin down-regulates acyl-coenzyme A: cholesterol acyltransferase-1 in cultured human monocyte-derived macrophages. Biochem Biophys Res Commun 317: 831-836. (Pubitemid 38481447)
36. Ganguly R, Schram K, Fang X, Kim M, Rodrigues B, Thong FS, et al,. (2011). Adiponectin increases LPL activity via RhoA/ROCK-mediated actin remodelling in adult rat cardiomyocytes. Endocrinology 152: 247-254.
37. Goldstein BJ, Scalia RG, Ma XL, (2009). Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med 6: 27-35.
38. Gonon AT, Widegren U, Bulhak A, Salehzadeh F, Persson J, Sjoquist PO, et al,. (2008). Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide. Cardiovasc Res 78: 116-122. (Pubitemid 351430967)
39. Hashimoto N, Kanda J, Nakamura T, Horie A, Kurosawa H, Hashimoto T, et al,. (2006). Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metabolism 55: 1653-1657. (Pubitemid 44827133)
40. Heiker JT, Wottawah CM, Juhl C, Kosel D, Morl K, Beck-Sickinger AG, (2009). Protein kinase CK2 interacts with adiponectin receptor 1 and participates in adiponectin signaling. Cell Signal 21: 936-942.
41. Hiuge A, Tenenbaum A, Maeda N, Benderly M, Kumada M, Fisman EZ, et al,. (2007). Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level. Arterioscler Thromb Vasc Biol 27: 635-641.
42. Hiuge-Shimizu A, Maeda N, Hirata A, Nakatsuji H, Nakamura K, Okuno A, et al,. (2011). Dynamic Changes of Adiponectin and S100A8 Levels by the Selective Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Rivoglitazone. Arterioscler Thromb Vasc Biol 31: 792-799.
43. Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, Bui HH, et al,. (2011). Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17: 55-63.
44. Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P, (2008). Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 27: 363-370.
45. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF, (2004). T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A 101: 10308-10313. (Pubitemid 38924921)
46. Ikeda Y, Ohashi K, Shibata R, Pimentel DR, Kihara S, Ouchi N, et al,. (2008). Cyclooxygenase-2 induction by adiponectin is regulated by a sphingosine kinase-1 dependent mechanism in cardiac myocytes. FEBS Lett 582: 1147-1150.
47. Imatoh T, Miyazaki M, Momose Y, Tanihara S, Une H, (2008). Adiponectin levels associated with the development of hypertension: a prospective study. Hypertens Res 31: 229-233. (Pubitemid 351461101)
48. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, et al,. (2010). Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 464: 1313-1319.
49. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, et al,. (2004). Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43: 1318-1323. (Pubitemid 38691756)
50. Kadowaki T, Yamauchi T, (2005). Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451. (Pubitemid 40686653)
51. Karastergiou K, Evans I, Ogston N, Miheisi N, Nair D, Kaski JC, et al,. (2010). Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells. Arterioscler Thromb Vasc Biol 30: 1340-1346.
52. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, et al,. (2007). Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621-2637. (Pubitemid 47494363)
53. Kim JE, Song SE, Kim YW, Kim JY, Park SC, Park YK, et al,. (2010). Adiponectin inhibits palmitate-induced apoptosis through suppression of reactive oxygen species in endothelial cells: involvement of cAMP/protein kinase A and AMP-activated protein kinase. J Endocrinol 207: 35-44.
54. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, et al,. (2005). Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112: 1756-1762. (Pubitemid 41372115)
55. Kobashi C, Urakaze M, Kishida M, Kibayashi E, Kobayashi H, Kihara S, et al,. (2005). Adiponectin inhibits endothelial synthesis of interleukin-8. Circ Res 97: 1245-1252.
56. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, et al,. (2004). Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94: e27-e31.
57. Koenig W, Khuseyinova N, Baumert J, Meisinger C, Lowel H, (2006). Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J Am Coll Cardiol 48: 1369-1377. (Pubitemid 44436825)
58. Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Seo YH, et al,. (2004). Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients. Circulation 110: 3687-3692. (Pubitemid 39665258)
59. Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Seo YH, et al,. (2005). Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia. J Am Coll Cardiol 45: 1649-1653. (Pubitemid 40704501)
60. Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Kim JA, et al,. (2006). Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients. Diabetes Care 29: 195-201. (Pubitemid 44106491)
61. Kondo M, Shibata R, Miura R, Shimano M, Kondo K, Li P, et al,. (2009). Caloric restriction stimulates revascularization in response to ischemia via adiponectin-mediated activation of endothelial nitric-oxide synthase. J Biol Chem 284: 1718-1724.
62. Kondo K, Shibata R, Unno K, Shimano M, Ishii M, Kito T, et al,. (2010). Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model. Circ Cardiovasc Interv 3: 166-173.
63. Konishi M, Haraguchi G, Ohigashi H, Ishihara T, Saito K, Nakano Y, et al,. (2011). Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation. Cardiovasc Res 89: 309-319.
64. Kotani K, Sakane N, Saiga K, Kurozawa Y, (2005). Leptin: adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intima-media thickness. Diabetologia 48: 2684-2686. (Pubitemid 41738239)
65. Kotani K, Shimohiro H, Sakane N, (2008). The relationship between leptin: adiponectin ratio and carotid intima-media thickness in asymptomatic females. Stroke 39: e32-e33. Author reply e34. (Pubitemid 351619499)
66. Kozakova M, Muscelli E, Flyvbjerg A, Frystyk J, Morizzo C, Palombo C, et al,. (2008). Adiponectin and left ventricular structure and function in healthy adults. J Clin Endocrinol Metab 93: 2811-2818. (Pubitemid 352008556)
67. Kriketos AD, Gan SK, Poynten AM, Furler SM, Chisholm DJ, Campbell LV, (2004). Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care 27: 629-630. (Pubitemid 38174107)
68. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al,. (2003). Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23: 85-89. (Pubitemid 36091630)
69. Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, et al,. (2004). Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 109: 2046-2049. (Pubitemid 38620209)
70. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT, (2006). Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55: 249-259. (Pubitemid 43343322)
71. Laughlin GA, Barrett-Connor E, May S, Langenberg C, (2007). Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol 165: 164-174. (Pubitemid 46096378)
72. Lefils J, Geloen A, Vidal H, Lagarde M, Bernoud-Hubac N, (2010). Dietary DHA: time course of tissue uptake and effects on cytokine secretion in mice. Br J Nutr 104: 1304-1312.
73. Li CJ, Sun HW, Zhu FL, Chen L, Rong YY, Zhang Y, et al,. (2007). Local adiponectin treatment reduces atherosclerotic plaque size in rabbits. J Endocrinol 193: 137-145. (Pubitemid 46638540)
74. Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF, et al,. (2008). Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 57: 1526-1535.
75. Li P, Shibata R, Unno K, Shimano M, Furukawa M, Ohashi T, et al,. (2010). Evidence for the importance of adiponectin in the cardioprotective effects of pioglitazone. Hypertension 55: 69-75.
76. Lin LY, Lin CY, Su TC, Liau CS, (2004). Angiotensin II-induced apoptosis in human endothelial cells is inhibited by adiponectin through restoration of the association between endothelial nitric oxide synthase and heat shock protein 90. FEBS Lett 574: 106-110.
77. Lin HV, Kim JY, Pocai A, Rossetti L, Shapiro L, Scherer PE, et al,. (2007). Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice. Diabetes 56: 1969-1976. (Pubitemid 47195822)
78. Lincoff AM, Wolski K, Nicholls SJ, Nissen SE, (2007). Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 298: 1180-1188. (Pubitemid 47403104)
79. Liu Y, Michael MD, Kash S, Bensch WR, Monia BP, Murray SF, et al,. (2007). Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. Endocrinology 148: 683-692. (Pubitemid 46143170)
80. Liu M, Zhou L, Xu A, Lam KS, Wetzel MD, Xiang R, et al,. (2008). A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. Proc Natl Acad Sci U S A 105: 18302-18307.
81. Lo J, Dolan SE, Kanter JR, Hemphill LC, Connelly JM, Lees RS, et al,. (2006). Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women. J Clin Endocrinol Metab 91: 1677-1682.
82. Lovren F, Pan Y, Quan A, Szmitko PE, Singh KK, Shukla PC, et al,. (2010). Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. Am J Physiol Heart Circ Physiol 299: H656-H663.
83. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K, (1996). cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221: 286-289. (Pubitemid 26136463)
84. Magkos F, Sidossis LS, (2007). Recent advances in the measurement of adiponectin isoform distribution. Curr Opin Clin Nutr Metab Care 10: 571-575. (Pubitemid 47254717)
85. Maiolino G, Cesari M, Antezza K, Zanchetta M, Pedon L, Pessina AC, et al,. (2007). Prognostic effect of plasma adiponectin (ADPN) in non diabetic high-risk patients. Hypertension 50: 818-818.
86. Maiolino G, Cesari M, Sticchi D, Zanchetta M, Pedon L, Antezza K, et al,. (2008). Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients. J Clin Endocrinol Metab 93: 3333-3340.
87. Mao X, Kikani CK, Riojas RA, Langlais P, Wang L, Ramos FJ, et al,. (2006). APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 8: 516-523.
88. Martos-Moreno GA, Barrios V, Martinez G, Hawkins F, Argente J, (2010). Effect of weight loss on high-molecular weight adiponectin in obese children. Obesity (Silver Spring) 18: 2288-2294.
89. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, et al,. (2002). Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 277: 37487-37491.
90. Matsuoka N, Ogawa Y, Masuzaki H, Ebihara K, Aizawa-Abe M, Satoh N, et al,. (2001). Decreased triglyceride-rich lipoproteins in transgenic skinny mice overexpressing leptin. Am J Physiol Endocrinol Metab 280: E334-E339.
91. Matsushita K, Yatsuya H, Tamakoshi K, Muramatsu T, Mitsuhashi H, Shibata R, et al,. (2007). Inverse association of adiponectin with insulin resistance is attenuated with the escalation of insulin resistance: a possible finding of adiponectin resistance. Circulation 116: 814.
92. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al,. (2003). Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108: 2460-2466. (Pubitemid 37444406)
93. Mazzone T, Meyer PM, Feinstein SB, Davidson MH, Kondos GT, D'Agostino RB, et al,. (2006). Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. JAMA 296: 2572-2581. (Pubitemid 44903861)
94. Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, et al,. (2006). Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 17: 2599-2606. (Pubitemid 44300977)
95. Mitsuhashi H, Yatsuya H, Tamakoshi K, Matsushita K, Otsuka R, Wada K, et al,. (2007). Adiponectin level and left ventricular hypertrophy in Japanese men. Hypertension 49: 1448-1454. (Pubitemid 46809393)
96. Motobayashi Y, Izawa-Ishizawa Y, Ishizawa K, Orino S, Yamaguchi K, Kawazoe K, et al,. (2009). Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells. Hypertens Res 32: 188-193.
97. Motoshima H, Wu X, Mahadev K, Goldstein BJ, (2004). Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun 315: 264-271. (Pubitemid 38183103)
98. Mullen KL, Smith AC, Junkin KA, Dyck DJ, (2007). Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats. Am J Physiol Endocrinol Metab 293: E83-E90. (Pubitemid 47105920)
99. Nagao K, Inoue N, Wang YM, Yanagita T, (2003). Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa/fa) rats. Biochem Biophys Res Commun 310: 562-566. (Pubitemid 37163701)
100. Nakamura N, Naruse K, Matsuki T, Hamada Y, Nakashima E, Kamiya H, et al,. (2009). Adiponectin promotes migration activities of endothelial progenitor cells via Cdc42/Rac1. FEBS Lett 583: 2457-2463.
101. Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK, Trumbauer ME, et al,. (2006). Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281: 2654-2660. (Pubitemid 43845727)
102. Nichols WW, Pepine CJ, O'Rourke MF, (1999). Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke. N Engl J Med 340: 1762-1763. (Pubitemid 29252609)
103. Nilsson PM, Engstrom G, Hedblad B, Frystyk J, Persson MM, Berglund G, et al,. (2006). Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance. Arterioscler Thromb Vasc Biol 26: 2758-2762.
104. Nissen SE, Wolski K, (2007). Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356: 2457-2471. (Pubitemid 46919772)
105. Norata GD, Raselli S, Grigore L, Garlaschelli K, Dozio E, Magni P, et al,. (2007). Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 38: 2844-2846. (Pubitemid 47494027)
106. Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, Gokce N, et al,. (2010). Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 285: 6153-6160.
107. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, et al,. (2002). Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106: 2767-2770. (Pubitemid 35396973)
108. Okui H, Hamasaki S, Ishida S, Kataoka T, Orihara K, Fukudome T, et al,. (2008). Adiponectin is a better predictor of endothelial function of the coronary artery than HOMA-R, body mass index, immunoreactive insulin, or triglycerides. Int J Cardiol 126: 53-61. (Pubitemid 351509627)
109. Ong KL, Li M, Tso AW, Xu A, Cherny SS, Sham PC, et al,. (2010). Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. Eur J Endocrinol 163: 251-257.
110. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al,. (2000). Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102: 1296-1301.
111. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al,. (2001). Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103: 1057-1063. (Pubitemid 32200177)
112. Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, et al,. (2003a). Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 42: 231-234. (Pubitemid 37093465)
113. Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, et al,. (2003b). Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 42: 231-234. (Pubitemid 37093465)
114. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, et al,. (2004). Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279: 1304-1309. (Pubitemid 38082655)
115. Ouedraogo R, Wu X, Xu SQ, Fuchsel L, Motoshima H, Mahadev K, et al,. (2006). Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 55: 1840-1846. (Pubitemid 44324141)
116. Ouedraogo R, Gong Y, Berzins B, Wu X, Mahadev K, Hough K, et al,. (2007). Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest 117: 1718-1726. (Pubitemid 46871356)
117. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, et al,. (2004a). Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279: 12152-12162. (Pubitemid 38445780)
118. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, et al,. (2004b). Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279: 12152-12162. (Pubitemid 38445780)
119. Park PH, McMullen MR, Huang H, Thakur V, Nagy LE, (2007). Short-term treatment of RAW264.7 macrophages with adiponectin increases tumor necrosis factor-alpha (TNF-alpha) expression via ERK1/2 activation and Egr-1 expression: role of TNF-alpha in adiponectin-stimulated interleukin-10 production. J Biol Chem 282: 21695-21703. (Pubitemid 47195777)
120. Park PH, Huang H, McMullen MR, Bryan K, Nagy LE, (2008). Activation of cyclic-AMP response element binding protein contributes to adiponectin- stimulated interleukin-10 expression in RAW 264.7 macrophages. J Leukoc Biol 83: 1258-1266. (Pubitemid 351960358)
121. Patel S, Flyvbjerg A, Kozakova M, Frystyk J, Ibrahim IM, Petrie JR, et al,. (2008). Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. Eur Heart J 29: 386-393. (Pubitemid 351197748)
122. Phillips SA, Kung J, Ciaraldi TP, Choe C, Christiansen L, Mudaliar S, et al,. (2009). Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans. Am J Physiol Endocrinol Metab 297: E767-E773.
123. Pilz S, Horejsi R, Moller R, Almer G, Scharnagl H, Stojakovic T, et al,. (2005). Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 90: 4792-4796. (Pubitemid 41159373)
124. Pilz S, Mangge H, Wellnitz B, Seelhorst U, Winkelmann BR, Tiran B, et al,. (2006). Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab 91: 4277-4286. (Pubitemid 44833399)
125. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB, (2004). Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291: 1730-1737. (Pubitemid 38489895)
126. Plant S, Shand B, Elder P, Scott R, (2008). Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins. Diab Vasc Dis Res 5: 102-108. (Pubitemid 351839281)
127. Qiang L, Wang H, Farmer SR, (2007). Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha. Mol Cell Biol 27: 4698-4707. (Pubitemid 47016124)
128. Rae C, Graham A, (2006). Human resistin promotes macrophage lipid accumulation. Diabetologia 49: 1112-1114.
129. Richards AA, Colgrave ML, Zhang J, Webster J, Simpson F, Preston E, et al,. (2010). Sialic acid modification of adiponectin is not required for multimerization or secretion but determines half-life in circulation. Mol Endocrinol 24: 229-239.
130. Rosenson RS, (2009). Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients. Obesity (Silver Spring) 17: 504-509.
131. Rossi AS, Lombardo YB, Lacorte JM, Chicco AG, Rouault C, Slama G, et al,. (2005). Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. Am J Physiol Regul Integr Comp Physiol 289: R486-R494. (Pubitemid 41060504)
132. Salvado MD, Alfranca A, Escolano A, Haeggstrom JZ, Redondo JM, (2009). COX-2 limits prostanoid production in activated HUVECs and is a source of PGH2 for transcellular metabolism to PGE2 by tumor cells. Arterioscler Thromb Vasc Biol 29: 1131-1137.
133. Sambuceti G, Morbelli S, Vanella L, Kusmic C, Marini C, Massollo M, et al,. (2009). Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectin. Stem Cells 27: 399-407.
134. Sato C, Yasukawa Z, Honda N, Matsuda T, Kitajima K, (2001). Identification and adipocyte differentiation-dependent expression of the unique disialic acid residue in an adipose tissue-specific glycoprotein, adipo Q. J Biol Chem 276: 28849-28856.
135. Satoh N, Naruse M, Usui T, Tagami T, Suganami T, Yamada K, et al,. (2004). Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 27: 2488-2490. (Pubitemid 39281406)
136. Schmid PM, Resch M, Steege A, Fredersdorf-Hahn S, Stoelcker B, Birner C, et al,. (2011). Globular and Full-Length Adiponectin Induce NO-Dependent Vasodilation in Resistance Arteries of Zucker Lean but Not Zucker Diabetic Fatty Rats. Am J Hypertens 243: 270-277.
137. Seeger FH, Haendeler J, Walter DH, Rochwalsky U, Reinhold J, Urbich C, et al,. (2005). p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111: 1184-1191. (Pubitemid 40365481)
138. Sekine S, Sasanuki S, Murano Y, Aoyama T, Takeuchi H, (2008). Alpha-linolenic acid-rich flaxseed oil ingestion increases plasma adiponectin level in rats. Int J Vitam Nutr Res 78: 223-229.
139. Semenkovich CF, (2005). TZDs and diabetes: testing the waters. Nat Med 11: 822-824. (Pubitemid 41161107)
140. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, et al,. (2004a). Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10: 1384-1389. (Pubitemid 40022722)
141. Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T, Walsh K, (2004b). Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem 279: 28670-28674. (Pubitemid 38900150)
142. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, et al,. (2005). Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11: 1096-1103. (Pubitemid 41486832)
143. Shibata R, Skurk C, Ouchi N, Galasso G, Kondo K, Ohashi T, et al,. (2008). Adiponectin promotes endothelial progenitor cell number and function. FEBS Lett 582: 1607-1612.
144. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, et al,. (2003). Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 88: 3236-3240. (Pubitemid 36877499)
145. Shimano M, Ouchi N, Shibata R, Ohashi K, Pimentel DR, Murohara T, et al,. (2010). Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response. J Mol Cell Cardiol 49: 210-220.
146. Shinmura K, Tamaki K, Saito K, Nakano Y, Tobe T, Bolli R, (2007). Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase. Circulation 116: 2809-2817. (Pubitemid 350291223)
147. Skurk C, Wittchen F, Suckau L, Witt H, Noutsias M, Fechner H, et al,. (2008). Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. Eur Heart J 29: 1168-1180. (Pubitemid 351844892)
148. Sorrentino SA, Bahlmann FH, Besler C, Muller M, Schulz S, Kirchhoff N, et al,. (2007). Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 116: 163-173. (Pubitemid 47057522)
149. Stumvoll M, Tschritter O, Fritsche A, Staiger H, Renn W, Weisser M, et al,. (2002). Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 51: 37-41. (Pubitemid 34517977)
150. Summer R, Fiack CA, Ikeda Y, Sato K, Dwyer D, Ouchi N, et al,. (2009). Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease. Am J Physiol Lung Cell Mol Physiol 297: L432-L438.
151. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S, (2003). Endothelial progenitor cells: new hope for a broken heart. Circulation 107: 3093-3100. (Pubitemid 36758985)
152. Tan KC, Xu A, Chow WS, Lam MC, Ai VH, Tam SC, et al,. (2004). Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89: 765-769. (Pubitemid 38269891)
153. Tao L, Gao E, Jiao X, Yuan Y, Li S, Christopher TA, et al,. (2007). Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115: 1408-1416. (Pubitemid 46648376)
154. Tao L, Wang Y, Gao E, Zhang H, Yuan Y, Lau WB, et al,. (2010). Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction. Circ Res 106: 409-417.
155. Terra X, Montagut G, Bustos M, Llopiz N, Ardevol A, Blade C, et al,. (2009). Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet. J Nutr Biochem 20: 210-218.
156. Torigoe M, Matsui H, Ogawa Y, Murakami H, Murakami R, Cheng XW, et al,. (2007). Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men. Clin Endocrinol (Oxf) 67: 276-281. (Pubitemid 47076306)
157. Tsao TS, Tomas E, Murrey HE, Hug C, Lee DH, Ruderman NB, et al,. (2003). Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem 278: 50810-50817. (Pubitemid 37548930)
158. Tsubakio-Yamamoto K, Matsuura F, Koseki M, Oku H, Sandoval JC, Inagaki M, et al,. (2008). Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages. Biochem Biophys Res Commun 375: 390-394.
159. Van Berendoncks AM, Garnier A, Beckers P, Hoymans VY, Possemiers N, Fortin D, et al,. (2010). Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail 3: 185-194.
160. Wang ZV, Scherer PE, (2008). Adiponectin, cardiovascular function, and hypertension. Hypertension 51: 8-14. (Pubitemid 350307092)
161. Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper GJ, et al,. (2005). Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280: 18341-18347. (Pubitemid 41389081)
162. Wang ZV, Schraw TD, Kim JY, Khan T, Rajala MW, Follenzi A, et al,. (2007). Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol Cell Biol 27: 3716-3731. (Pubitemid 46726179)
163. Wang Y, Lam KS, Yau MH, Xu A, (2008). Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J 409: 623-633. (Pubitemid 351214189)
164. Wang C, Xin X, Xiang R, Ramos FJ, Liu M, Lee HJ, et al,. (2009a). Yin-Yang regulation of adiponectin signaling by APPL isoforms in muscle cells. J Biol Chem 284: 31608-31615.
165. Wang Y, Gao E, Tao L, Lau WB, Yuan Y, Goldstein BJ, et al,. (2009b). AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin. Circulation 119: 835-844.
166. Wang Y, Lau WB, Gao E, Tao L, Yuan Y, Li R, et al,. (2010). Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury. Am J Physiol Endocrinol Metab 298: E663-E670.
167. Wang A, Liu M, Liu X, Dong LQ, Glickman RD, Slaga TJ, et al,. (2011). Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-L. J Biol Chem 286: 60-66.
168. Wegiel B, Gallo DJ, Raman KG, Karlsson JM, Ozanich B, Chin BY, et al,. (2010). Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury. Circulation 121: 537-548.
169. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al,. (2009). Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373: 1083-1096.
170. Wu X, Mahadev K, Fuchsel L, Ouedraogo R, Xu SQ, Goldstein BJ, (2007). Adiponectin suppresses IkappaB kinase activation induced by tumor necrosis factor-alpha or high glucose in endothelial cells: role of cAMP and AMP kinase signaling. Am J Physiol Endocrinol Metab 293: E1836-E1844. (Pubitemid 350258452)
171. Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA, Spurlock ME, (2004). Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 316: 924-929. (Pubitemid 38368041)
172. Xi W, Satoh H, Kase H, Suzuki K, Hattori Y, (2005). Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. Biochem Biophys Res Commun 332: 200-205. (Pubitemid 40719474)
173. Xu A, Wang H, Hoo RL, Sweeney G, Vanhoutte PM, Wang Y, et al,. (2009a). Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice. Endocrinology 150: 625-633.
174. Xu Y, Wang N, Ling F, Li P, Gao Y, (2009b). Receptor for activated C-kinase 1, a novel binding partner of adiponectin receptor 1. Biochem Biophys Res Commun 378: 95-98.
175. Xu A, Wang Y, Lam KS, Vanhoutte PM, (2010a). Vascular actions of adipokines molecular mechanisms and therapeutic implications. Adv Pharmacol 60: 229-255.
176. Xu Y, Zhang C, Wang N, Ling F, Li P, Gao Y, et al,. (2010b). Adiponectin inhibits lymphotoxin-beta receptor-mediated NF-KappaB signaling in human umbilical vein endothelial cells. Biochem Biophys Res Commun 404: 1060-1064.
177. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, et al,. (2003a). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769. (Pubitemid 36735700)
178. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, et al,. (2003b). Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278: 2461-2468. (Pubitemid 36801322)
179. Yamaguchi N, Argueta JG, Masuhiro Y, Kagishita M, Nonaka K, Saito T, et al,. (2005). Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett 579: 6821-6826. (Pubitemid 41773693)
180. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, et al,. (2007). Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13: 332-339. (Pubitemid 46376688)
181. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al,. (2001). Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86: 3815-3819. (Pubitemid 32755982)
182. Yi W, Sun Y, Gao E, Wei X, Lau W, Zheng Q, et al,. (2010). Reduced cardioprotective action of adiponectin in high fat diet induced type II diabetic mice and its underlying mechanisms. Antioxid Redox Signal. Epub 2010 Nov 21 doi: 10.1089/ars.2010.3722.
183. Yilmaz MI, Sonmez A, Caglar K, Celik T, Yenicesu M, Eyileten T, et al,. (2007). Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Nephrology (Carlton) 12: 147-153. (Pubitemid 46426854)
184. Zampetaki A, Kirton JP, Xu Q, (2008). Vascular repair by endothelial progenitor cells. Cardiovasc Res 78: 413-421. (Pubitemid 351769775)
185. Zhang P, Wang Y, Fan Y, Tang Z, Wang N, (2009). Overexpression of adiponectin receptors potentiates the antiinflammatory action of subeffective dose of globular adiponectin in vascular endothelial cells. Arterioscler Thromb Vasc Biol 29: 67-74.
186. Zhang H, Park Y, Zhang C, (2010). Coronary and aortic endothelial function affected by feedback between adiponectin and tumor necrosis factor alpha in type 2 diabetic mice. Arterioscler Thromb Vasc Biol 30: 2156-2163.
187. Zhou L, Deepa SS, Etzler JC, Ryu J, Mao X, Fang Q, et al,. (2009). Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1/LKB1-dependent and phospholipase C/Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent pathways. J Biol Chem 284: 22426-22435.
188. Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A, (2008). Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 114: 361-374. (Pubitemid 351397385)